Insulin Lispro has 37 known drug interactions based on U.S. FDA drug labeling data. 5 are classified as major interactions requiring close medical supervision. Notable interactions include combinations with Disopyramide, Fluoxetine, Octreotide. Patients taking Insulin Lispro should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.
- Total
- 37
- Major
- 5
- Moderate
- 30
Major (5)
- Insulin Lispro + Disopyramide— May increase the risk of hypoglycemia; dose adjustment and increased glucose monitoring required.
- Insulin Lispro + Fluoxetine— May increase the risk of hypoglycemia; dose adjustment and increased glucose monitoring required.
- Insulin Lispro + Octreotide— Somatostatin analog that may increase the risk of hypoglycemia; dose adjustment and increased glucose monitoring require…
- Insulin Lispro + Pentoxifylline— May increase the risk of hypoglycemia; dose adjustment and increased glucose monitoring required.
- Insulin Lispro + Pramlintide— May increase the risk of hypoglycemia; dose adjustment and increased glucose monitoring required.
Moderate (30)
- Insulin Lispro + Albuterol— Sympathomimetic agent that may decrease blood glucose lowering effect; dose adjustment and increased glucose monitoring …
- Insulin Lispro + Alcohol— May increase or decrease blood glucose lowering effect; dose adjustment and increased glucose monitoring required.
- Insulin Lispro + Angiotensin Ii— May increase risk of hypoglycemia. Dose adjustment and increased glucose monitoring may be required.
- Insulin Lispro + Clonidine— May increase or decrease blood glucose lowering effect and may blunt signs/symptoms of hypoglycemia; increased glucose m…
- Insulin Lispro + Clozapine— Atypical antipsychotic that may decrease blood glucose lowering effect; dose adjustment and increased glucose monitoring…
- Insulin Lispro + Corticosteroids— May decrease the blood glucose lowering effect. Dose adjustment and increased frequency of glucose monitoring may be req…
- Insulin Lispro + Danazol— May decrease blood glucose lowering effect; dose adjustment and increased glucose monitoring required.
- Insulin Lispro + Diuretics— May decrease the blood glucose lowering effect. Dose adjustment and increased frequency of glucose monitoring may be req…
- Insulin Lispro + Epinephrine— Sympathomimetic agent that may decrease blood glucose lowering effect; dose adjustment and increased glucose monitoring …
- Insulin Lispro + Estrogens— May decrease the blood glucose lowering effect. Dose adjustment and increased frequency of glucose monitoring may be req…
- Insulin Lispro + Fibrates— May increase the risk of hypoglycemia. Dose adjustment and increased frequency of glucose monitoring may be required.
- Insulin Lispro + Glucagon— May decrease blood glucose lowering effect; dose adjustment and increased glucose monitoring required.
- Insulin Lispro + Guanethidine— May blunt signs and symptoms of hypoglycemia; increased glucose monitoring required.
- Insulin Lispro + Isoniazid— May decrease blood glucose lowering effect; dose adjustment and increased glucose monitoring required.
- Insulin Lispro + Lithium— May increase or decrease blood glucose lowering effect; dose adjustment and increased glucose monitoring required.
- Insulin Lispro + Macrolide Antibiotics— May increase risk of hypoglycemia. Dose adjustment and increased glucose monitoring may be required.
- Insulin Lispro + Mao Inhibitors— May increase risk of hypoglycemia. Dose adjustment and increased glucose monitoring may be required.
- Insulin Lispro + Monoamine Oxidase Inhibitors (Maois)— May increase risk of hypoglycemia. Dose adjustment and increased glucose monitoring may be required.
- Insulin Lispro + Niacin— May decrease blood glucose lowering effect; dose adjustment and increased glucose monitoring required.
- Insulin Lispro + Nonselective Beta-Adrenergic Antagonists— May increase or decrease blood glucose lowering effect and may blunt signs and symptoms of hypoglycemia. Increased gluco…
- Insulin Lispro + Olanzapine— Atypical antipsychotic that may decrease blood glucose lowering effect; dose adjustment and increased glucose monitoring…
- Insulin Lispro + Oral Contraceptives— May decrease blood glucose lowering effect. Dose adjustment and increased glucose monitoring may be required.
- Insulin Lispro + Pentamidine— May cause hypoglycemia followed sometimes by hyperglycemia; dose adjustment and increased glucose monitoring required.
- Insulin Lispro + Phenothiazines— May decrease the blood glucose lowering effect. Dose adjustment and increased frequency of glucose monitoring may be req…
- Insulin Lispro + Protease Inhibitors— May decrease blood glucose lowering effect. Dose adjustment and increased glucose monitoring may be required.
- Insulin Lispro + Reserpine— May blunt signs and symptoms of hypoglycemia; increased glucose monitoring required.
- Insulin Lispro + Salicylates— May increase the risk of hypoglycemia. Dose adjustment and increased frequency of glucose monitoring may be required.
- Insulin Lispro + Somatropin— May decrease blood glucose lowering effect; dose adjustment and increased glucose monitoring required.
- Insulin Lispro + Terbutaline— Sympathomimetic agent that may decrease blood glucose lowering effect; dose adjustment and increased glucose monitoring …
- Insulin Lispro + Thyroid Hormones— May decrease the blood glucose lowering effect. Dose adjustment and increased frequency of glucose monitoring may be req…